Perspectives on Resolving Diagnostic Challenges between Myocardial Infarction and Takotsubo Cardiomyopathy Leveraging Artificial Intelligence

Serin Moideen Sheriff, Aaftab Sethi, Divyanshi Sood, Sourav Bansal, Aastha Goudel, Manish Murlidhar, Devanshi N. Damani, Kanchan Kulkarni, Shivaram P. Arunachalam
{"title":"Perspectives on Resolving Diagnostic Challenges between Myocardial Infarction and Takotsubo Cardiomyopathy Leveraging Artificial Intelligence","authors":"Serin Moideen Sheriff, Aaftab Sethi, Divyanshi Sood, Sourav Bansal, Aastha Goudel, Manish Murlidhar, Devanshi N. Damani, Kanchan Kulkarni, Shivaram P. Arunachalam","doi":"10.3390/biomedinformatics4020072","DOIUrl":null,"url":null,"abstract":"Background: cardiovascular diseases, including acute myocardial infarction (AMI) and takotsubo cardiomyopathy (TTC), are significant causes of morbidity and mortality worldwide. Timely differentiation of these conditions is essential for effective patient management and improved outcomes. Methods: We conducted a review focusing on studies that applied artificial intelligence (AI) techniques to differentiate between acute myocardial infarction (AMI) and takotsubo cardiomyopathy (TTC). Inclusion criteria comprised studies utilizing various AI modalities, such as deep learning, ensemble methods, or other machine learning techniques, for discrimination between AMI and TTC. Additionally, studies employing imaging techniques, including echocardiography, cardiac magnetic resonance imaging, and coronary angiography, for cardiac disease diagnosis were considered. Publications included were limited to those available in peer-reviewed journals. Exclusion criteria were applied to studies not relevant to the discrimination between AMI and TTC, lacking detailed methodology or results pertinent to the AI application in cardiac disease diagnosis, not utilizing AI modalities or relying solely on invasive techniques for differentiation between AMI and TTC, and non-English publications. Results: The strengths and limitations of AI-based approaches are critically evaluated, including factors affecting performance, such as reliability and generalizability. The review delves into challenges associated with model interpretability, ethical implications, patient perspectives, and inconsistent image quality due to manual dependency, highlighting the need for further research. Conclusions: This review article highlights the promising advantages of AI technologies in distinguishing AMI from TTC, enabling early diagnosis and personalized treatments. However, extensive validation and real-world implementation are necessary before integrating AI tools into routine clinical practice. It is vital to emphasize that while AI can efficiently assist, it cannot entirely replace physicians. Collaborative efforts among clinicians, researchers, and AI experts are essential to unlock the potential of these transformative technologies fully.","PeriodicalId":72394,"journal":{"name":"BioMedInformatics","volume":"39 20","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BioMedInformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/biomedinformatics4020072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: cardiovascular diseases, including acute myocardial infarction (AMI) and takotsubo cardiomyopathy (TTC), are significant causes of morbidity and mortality worldwide. Timely differentiation of these conditions is essential for effective patient management and improved outcomes. Methods: We conducted a review focusing on studies that applied artificial intelligence (AI) techniques to differentiate between acute myocardial infarction (AMI) and takotsubo cardiomyopathy (TTC). Inclusion criteria comprised studies utilizing various AI modalities, such as deep learning, ensemble methods, or other machine learning techniques, for discrimination between AMI and TTC. Additionally, studies employing imaging techniques, including echocardiography, cardiac magnetic resonance imaging, and coronary angiography, for cardiac disease diagnosis were considered. Publications included were limited to those available in peer-reviewed journals. Exclusion criteria were applied to studies not relevant to the discrimination between AMI and TTC, lacking detailed methodology or results pertinent to the AI application in cardiac disease diagnosis, not utilizing AI modalities or relying solely on invasive techniques for differentiation between AMI and TTC, and non-English publications. Results: The strengths and limitations of AI-based approaches are critically evaluated, including factors affecting performance, such as reliability and generalizability. The review delves into challenges associated with model interpretability, ethical implications, patient perspectives, and inconsistent image quality due to manual dependency, highlighting the need for further research. Conclusions: This review article highlights the promising advantages of AI technologies in distinguishing AMI from TTC, enabling early diagnosis and personalized treatments. However, extensive validation and real-world implementation are necessary before integrating AI tools into routine clinical practice. It is vital to emphasize that while AI can efficiently assist, it cannot entirely replace physicians. Collaborative efforts among clinicians, researchers, and AI experts are essential to unlock the potential of these transformative technologies fully.
利用人工智能解决心肌梗死和塔克苏博心肌病诊断难题的视角
背景:心血管疾病,包括急性心肌梗死(AMI)和拓扑心肌病(TTC),是全球发病率和死亡率的重要原因。及时区分这些疾病对于有效管理患者和改善预后至关重要。方法:我们对应用人工智能(AI)技术区分急性心肌梗死(AMI)和塔克次博心肌病(TTC)的研究进行了综述。纳入标准包括利用各种人工智能模式(如深度学习、集合方法或其他机器学习技术)区分急性心肌梗死和 TTC 的研究。此外,还考虑采用超声心动图、心脏磁共振成像和冠状动脉造影等成像技术进行心脏疾病诊断的研究。纳入的文献仅限于在同行评审期刊上发表的文献。排除标准适用于与区分急性心肌梗死和急性心肌梗死无关的研究、缺乏详细方法或结果与人工智能在心脏疾病诊断中的应用有关的研究、未使用人工智能模式或仅依靠侵入性技术区分急性心肌梗死和急性心肌梗死的研究,以及非英文出版物。结果:对基于人工智能的方法的优势和局限性进行了严格评估,包括影响性能的因素,如可靠性和可推广性。综述深入探讨了与模型可解释性、伦理影响、患者观点以及人工依赖导致的图像质量不一致相关的挑战,强调了进一步研究的必要性。结论:这篇综述文章强调了人工智能技术在区分急性心肌梗死和急性心肌梗死、实现早期诊断和个性化治疗方面的优势。然而,在将人工智能工具纳入常规临床实践之前,还需要进行广泛的验证和实际应用。必须强调的是,虽然人工智能可以有效地提供帮助,但它不能完全取代医生。临床医生、研究人员和人工智能专家之间的合作对于充分释放这些变革性技术的潜力至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信